1.
Braz. j. infect. dis
;
11(4): 388-389, Aug. 2007.
Artigo
em Inglês
| LILACS
| ID: lil-460696
RESUMO
Ten patients with donovanosis were treated with thiamphenicol for two weeks. In eight of them, included two HIV infected patients, lesions healed. The safety profile of thiamphenicol makes it a useful and cost-effective agent in the management of donovanosis. Randomized controlled trials should be conducted with these treatment options.